Clinical Trial: An Open-Label Study of 50 mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women With Low Testosterone and HSDD
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Hypoactive Sexual Desire Disorder
Study Type: INTERVENTIONAL
Official Title: An Open-Label Pilot Study of the Pharmacokinetics and Safety of 50 Mg Oral Testosterone Undecanoate (Kyzatrex) in Menopausal Women With Low Testosterone and Hypoactive Sexual Desire Disorder
Brief Summary:
This is an unblinded study to be conducted at a single research center, San Diego Sexual Medicine.Eligible subjects will receive 50 mg capsules of Kyzatrax® to be taken orally daily over a 3-month period.Multiple blood samples will be taken at baseline and on days 7, 28 and 56 to assess safety and pharmacokinetics of the testosterone.After the informed consent is signed and for up to 84 days after baseline, subjects will have serial blood samples collected in addition to other routine study procedures (e.g.vital…
Read more